Yale child psychiatrist supports results of autism treatment study that shows a popular drug is ineffective

December 07, 1999

A treatment for autistic children that was touted by the media and anxious parents as a wonder drug has been shown to have no effect, highlighting the need for controlled studies, according to a Yale psychiatrist.

The drug secretin did no better at controlling autistic symptoms than a placebo, according to a study published in the December 9 issue of the New England Journal of Medicine. Conducted by researchers at a variety of institutions in North Carolina, the study looked at the effect of secretin, a gastrointestinal hormone, on 56 children with autism and similar disorders. They found that a single dose of secretin is not an effective treatment for autism, a brain disorder that begins in childhood and results in delayed or deviant social and communication skills.

The disorder affects one in approximately 2,000 children and there is no known cure. Parents often feel overwhelmed and devastated by this diagnosis and many turned to secretin after it was widely reported that it made remarkable improvement in an autistic child, according to Fred Volkmar, M.D., professor of child psychiatry at Yale School of Medicine and author of an editorial on the study.

"Parents scrambled to obtain this 'cure' for their children in the absence of data on safety and efficacy," Volkmar said. "Given the absence of a cure for autism, it is not surprising that a host of new treatments, often accompanied by extravagant claims for improvement, have inadequate data to back it up. What makes an effective television program may not make good science."

The willingness of parents to pursue unproven or emerging treatments is understandable because of the seriousness of autism, Volkmar said. But it is important that parents know that some interventions have been proven to be effective and helpful. Such treatments should not be lightly abandoned. For many children there are demonstrable and important benefits of behavioral therapies and educational interventions.

"For other treatments reliable data are minimal or absent," said Volkmar.

"Parents and professionals must struggle with making informed treatment decisions for individual children. These decisions should weigh the benefits and potential risks of treatment and information currently available on those treatments which have been demonstrated to be effective."

In his editorial, Volkmar adds that some proposed cures, such as injections of sheep brain extract, have obvious inherent physical dangers to children.

"The lesson to be learned from secretin relates to the relationship of science and the media as well as to the nature and treatment of autism," Volkmar said. "In the case of secretin, the extensive media attention in the absence of substantive data was clearly premature and unfortunate."
-end-


Yale University

Related Autism Articles from Brightsurf:

Autism-cholesterol link
Study identifies genetic link between cholesterol alterations and autism.

National Autism Indicators Report: the connection between autism and financial hardship
A.J. Drexel Autism Institute released the 2020 National Autism Indicators Report highlighting the financial challenges facing households of children with autism spectrum disorder (ASD), including higher levels of poverty, material hardship and medical expenses.

Autism risk estimated at 3 to 5% for children whose parents have a sibling with autism
Roughly 3 to 5% of children with an aunt or uncle with autism spectrum disorder (ASD) can also be expected to have ASD, compared to about 1.5% of children in the general population, according to a study funded by the National Institutes of Health.

Adulthood with autism
The independence that comes with growing up can be scary for any teenager, but for young adults with autism spectrum disorder and their caregivers, the transition from adolescence to adulthood can seem particularly daunting.

Brain protein mutation from child with autism causes autism-like behavioral change in mice
A de novo gene mutation that encodes a brain protein in a child with autism has been placed into the brains of mice.

Autism and theory of mind
Theory of mind, or the ability to represent other people's minds as distinct from one's own, can be difficult for people with autism.

Potential biomarker for autism
A study of young children with autism spectrum disorder published in JNeurosci reveals altered brain waves compared to typically developing children during a motor control task.

Autism often associated with multiple new mutations
Most autism cases are in families with no previous history of the disorder.

State laws requiring autism coverage by private insurers led to increases in autism care
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health has found that the enactment of state laws mandating coverage of autism spectrum disorder (ASD) was followed by sizable increases in insurer-covered ASD care and associated spending.

Autism's gender patterns
Having one child with autism is a well-known risk factor for having another one with the same disorder, but whether and how a sibling's gender influences this risk has remained largely unknown.

Read More: Autism News and Autism Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.